Completed PHASE3 INTERVENTIONAL 1-arm NCT03368066

Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?

Sponsor: University of Virginia

Conditions Adrenal Insufficiency Cirrhosis Lecithin Acyltransferase Deficiency Spur Cell Anemia

Interventions Cosyntropin

Updated 8 times since 2017 Last updated: Dec 8, 2021 Started: Jan 29, 2018 Primary completion: Mar 12, 2019 Completion: Mar 12, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03368066, this PHASE3 trial focuses on Adrenal Insufficiency and Cirrhosis and remains completed. Sponsored by University of Virginia, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2022 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Jan 2022 [monthly]

Completed PHASE3
Oct 2019 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed

▶ Show 3 earlier versions

Nov 2018 — Oct 2019 [monthly]

Recruiting PHASE3
Jun 2018 — Nov 2018 [monthly]

Recruiting PHASE3
Dec 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Virginia

Data source: University of Virginia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charlottesville, United States